POTENTIAL RE-RATE CATALYST EVENT: RESULTS, page-114

Consistency is most important at the moment. The EV/sales multiple is still so low relative to peers that it is obvious the market needs confirmation of sustained growth. Give the market proof of that and you rerate to a higher multiple (which would be 2-5x returns at least). Then the actual growth number becomes more important, as that will become the primary driver of the share price

I did say sensible as it was conservative and probably a good base for expectations (last thing we want to do is predict 200% growth and then be disappointed with "only" 100% growth lol). However I did mention that it wouldn't take many new doctors to lead to considerably higher figures (and I have to imagine they managed to get a few at the recent conferences and training events), and so it's pretty difficult to predict at this early stage